Understanding the Lived Experience of Fetal and Neonatal Alloimmune Thrombocytopenia: A Qualitative Study
American Journal of Perinatology Reports · 01.07.2026 · 16 (03) · e185-e194
DOI: 10.1055/a-2948-6561 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift American Journal of Perinatology Reports, erschienen am 01.07.2026. Verfasst von Ellen Elisabeth Johanna de Kreij und 6 weiteren Autor:innen. Beteiligte Einrichtung: Patient AuthorLandgraafthe Netherlands. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johnson & Johnson.
Abstract (Originalsprache)
Objective
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare alloimmune disease of pregnancy. This study aimed to better understand the disease burden of FNAIT and its impact on families through qualitative research. Study Design This exploratory qualitative study involved thematic analysis of semi-structured virtual interviews and group sessions (Cohort 1: October 2021–November 2024; Cohort 2: April–May 2025) with members of the FNAIT Patient Council from the United States, Canada, the United Kingdom, Australia, and the Netherlands, organized by Johnson & Johnson.
Results
There were 10 participants (9 female, 1 male) in Cohort 1 and 12 female participants in Cohort 2. Cohort 1 themes included the challenging and inconsistent diagnostic path, responsibility for self-education and self-advocacy, and navigation of unclear care pathways. Cohort 2 themes included the challenging diagnostic path, wider impacts on families and family planning, burdensome treatments, mental health, and opportunities to improve overall experiences.
Conclusion
These qualitative findings demonstrate the weight of the emotional, logistical, and financial burden placed on families affected by FNAIT. Unmet needs include improved antenatal screening and earlier diagnosis, less burdensome treatment, more psychosocial support, and improved awareness of FNAIT among healthcare providers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Patient AuthorLandgraafthe Netherlands.
- Patient AuthorSan FranciscoCaliforniaUnited States.
- NAITbabies.orgPenzanceCornwallUnited Kingdom of Great Britain and Northern Ireland.
- Johnson & JohnsonBredaThe Netherlands.
- Johnson & JohnsonHorshamPennsylvaniaUnited States.
- Department of Development and RegenerationKU LeuvenLeuvenBelgium.
ORCID-Profile: Ellen Elisabeth Johanna de Kreij, Melanie Mesch, Maartje Mangelaars, Lisa Shea, Roland Devlieger, R Katie Morris
Förderung
- Johnson & Johnson
Zitieren
APA
de Kreij, E. E. J., Mesch, M., Corke, S., Mangelaars, M., Shea, L., Devlieger, R., & Morris, R. K. (2026). Understanding the Lived Experience of Fetal and Neonatal Alloimmune Thrombocytopenia: A Qualitative Study. American Journal of Perinatology Reports, 16(03), e185-e194. https://doi.org/10.1055/a-2948-6561
Vancouver
de Kreij EEJ, Mesch M, Corke S, Mangelaars M, Shea L, Devlieger R, et al. Understanding the Lived Experience of Fetal and Neonatal Alloimmune Thrombocytopenia: A Qualitative Study. American Journal of Perinatology Reports. 2026;16(03):e185-e194. doi:10.1055/a-2948-6561
BibTeX
@article{deKreij2026,
author = {de Kreij, Ellen Elisabeth Johanna and Mesch, Melanie and Corke, Stacy and Mangelaars, Maartje and Shea, Lisa and Devlieger, Roland and Morris, R Katie},
title = {Understanding the Lived Experience of Fetal and Neonatal Alloimmune Thrombocytopenia: A Qualitative Study},
journal = {American Journal of Perinatology Reports},
year = {2026},
volume = {16},
number = {03},
pages = {e185--e194},
doi = {10.1055/a-2948-6561}
}
EUVIMED